Keith Katkin

Keith Katkin

Chairman bij ELEDON PHARMACEUTICALS, INC.

Vermogen: 1 M $ op 31-03-2024

52 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Keith A.
Katkin
is currently serving as the Chairman at Eledon Pharmaceuticals, Inc., an Independent Director at Syndax Pharmaceuticals, Inc., an Independent Director at Emergent BioSolutions, Inc., and a Director at both the Brain Injury Association of America, Inc. and Transposon Therapeutics, Inc. Previously, he held the positions of President, Chief Executive Officer & Director at Avanir Pharmaceuticals, Inc. from 2007 to 2016, President, Chief Executive Officer & Director at Urovant Sciences, Inc. from 2017 to 2020, Chief Executive Officer & Director at Urovant Sciences Ltd.
from 2018 to 2020, Chairman at Otic Pharma Ltd.
from 2015 to 2017, Independent Director at Rigel Pharmaceuticals, Inc. from 2015 to 2022, Independent Class III Director at Carbylan Therapeutics, Inc. from 2014 to 2016, and Vice President-Commercial Development at Peninsula Pharmaceuticals, Inc. from 2004 to 2005.
Mr. Katkin received his undergraduate degree from Indiana University in 1993 and his MBA from Anderson School of Management in 2000.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
08-03-2024 48 000 ( 0.06% ) 1 M $ 31-03-2024
25-05-2023 42 442 ( 0.08% ) 107 378 $ 31-03-2024
01-05-2023 677 ( 0.00% ) 1 395 $ 31-03-2024
31-01-2023 0 ( -.--% ) - $ 31-03-2024

Actieve functies van Keith Katkin

BedrijvenFunctieBegin
SYNDAX PHARMACEUTICALS, INC. Director/Board Member 29-03-2017
ELEDON PHARMACEUTICALS, INC. Chairman 01-05-2017
EMERGENT BIOSOLUTIONS INC. Director/Board Member 01-04-2022
Brain Injury Association of America, Inc. Director/Board Member -
Director/Board Member -
Alle actieve functies van Keith Katkin

Eerdere bekende functies van Keith Katkin

BedrijvenFunctieEinde
RIGEL PHARMACEUTICALS, INC. Director/Board Member 01-05-2022
UROVANT SCIENCES LTD. Chief Executive Officer 23-03-2020
Chief Executive Officer 01-01-2020
Director/Board Member 01-04-2017
░░░░ ░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
Ervaring van Keith Katkin in detail bekijken

Opleiding van Keith Katkin

Indiana University Undergraduate Degree
Anderson School of Management Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Keith Katkin in detail bekijken

Connecties

100 +

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven4
RIGEL PHARMACEUTICALS, INC.

Health Technology

SYNDAX PHARMACEUTICALS, INC.

Health Technology

EMERGENT BIOSOLUTIONS INC.

Health Technology

ELEDON PHARMACEUTICALS, INC.

Health Technology

Bedrijven in privébezit10

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Brain Injury Association of America, Inc.

Finance

Health Technology

Health Technology

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Keith Katkin